Spironolactone Tablet, Coated
Product Images NDC 50090-6458

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 50090-6458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve comparing the probability of an event over 42 months between Spironolactone and placebo groups. The y-axis represents probability, and the x-axis shows time in months. The chart includes sample sizes (Spironolactone n=822, placebo n=841) and a log-rank p-value indicating statistical significance.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart showing hazard ratios (HR) with 95% confidence intervals for different subgroups in a study comparing spironolactone and placebo. The subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4, with markers indicating whether spironolactone or placebo is favored.*
FDA Label Image

Label Image (Lbl500906458)

Label Image (Lbl500906458)
Spironolactone 50 mg coated tablets label by A-S Medication Solutions. The label includes NDC 50090-6458-0 and states each tablet contains USP Spironolactone 50 mg. Storage instructions specify 68 to 77 degrees Fahrenheit. The package contains 100 tablets in total.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone, displaying its molecular framework with labeled chemical groups as part of the drug's active ingredient representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.